Alpha 2.0
Login Register
» Articles » PMID: 39770988

Comparative Clinical Study on Magnesium Absorption and Side Effects After Oral Intake of Microencapsulated Magnesium (MAGSHAPE Microcapsules) Versus Other Magnesium Sources

Overview
Journal Nutrients
Date 2025 Jan 8
PMID 39770988
Authors
David Pajuelo
Justyna M Meissner
Teresa Negra
Alan Connolly
Jose L Mullor
Affiliations
Soon will be listed here.
Abstract

Background/objectives: Magnesium (Mg)-based food supplements contribute to the maintenance of adequate levels of Mg that are essential for overall health and well-being. The aim of this double-blind, randomized, cross-over clinical study was to assess the plasma Mg levels in volunteers following the oral administration of a magnesium-based nutraceutical ingredient, MAGSHAPE microcapsules (Mg-MS), in comparison to other commonly used magnesium sources, including the following: Mg Oxide (MgO), Mg Citrate (Mg-C), and Mg bisglycinate (Mg-BG).

Methods: A total of 40 healthy women and men were put on a low-Mg diet for 7 days, and after 8 h of fasting, a blood sample was taken from a digital puncture before (0 h) and 1 h, 4 h, and 6 h after the oral intake of each product.

Results: Our results showed that the blood plasma levels of Mg increased significantly at all tested time-points after the oral intake of Mg-MS, while the blood plasma levels of Mg increased significantly only after 1 and 4 h of the oral intake of MgO and Mg-C, respectively. However, no significant increase in Mg levels was observed upon the intake of Mg-BG. Interestingly, the Mg-MS microencapsulation technology was observed to enable a sustained increase in plasma Mg levels over the duration of this study, i.e., 1, 4, and 6 h after oral intake. A direct comparison of the increase in plasma Mg levels over the 6 h period revealed that the Mg-MS microencapsulation technology significantly increased Mg bioavailability compared to the non-microencapsulated MgO. Our study also showed that, compared to the other Mg sources tested, the Mg-MS microencapsulation technology reduced adverse side effects commonly associated with Mg supplementation, specifically with regard to increased intestinal motility and sensations of gastric heaviness following oral administration.

Conclusions: Altogether, this clinical study introduced MAGSHAPE microcapsules as a bioavailable and well-tolerated alternative to existing Mg-based ingredients used in food supplements.

References
1.
Afitska K, Clavel J, Kisters K, Vormann J, Werner T . Magnesium citrate supplementation decreased blood pressure and HbA1c in normomagnesemic subjects with metabolic syndrome: a 12-week, placebo-controlled, double-blinded pilot trial. Magnes Res. 2021; 34(3):130-139. DOI: 10.1684/mrh.2021.0489. View
2.
Bithi N, Ricks D, Walker B, Law C, Johnson-Davis K . Method validation of an inductively coupled plasma mass spectrometry (ICP-MS) assay for the analysis of magnesium, copper and zinc in red blood cells. J Mass Spectrom Adv Clin Lab. 2024; 34:21-27. PMC: 11513474. DOI: 10.1016/j.jmsacl.2024.10.003. View
3.
Afsharfar M, Shahraki M, Shakiba M, Asbaghi O, Dashipour A . The effects of magnesium supplementation on serum level of brain derived neurotrophic factor (BDNF) and depression status in patients with depression. Clin Nutr ESPEN. 2021; 42:381-386. DOI: 10.1016/j.clnesp.2020.12.022. View
4.
Nicar M, Pak C . Oral magnesium load test for the assessment of intestinal magnesium absorption. Application in control subjects, absorptive hypercalciuria, primary hyperparathyroidism, and hypoparathyroidism. Miner Electrolyte Metab. 1982; 8(1):44-51. View
5.
Zhang X, Del Gobbo L, Hruby A, Rosanoff A, He K, Dai Q . The Circulating Concentration and 24-h Urine Excretion of Magnesium Dose- and Time-Dependently Respond to Oral Magnesium Supplementation in a Meta-Analysis of Randomized Controlled Trials. J Nutr. 2016; 146(3):595-602. DOI: 10.3945/jn.115.223453. View